Jpmorgan Chase & CO Corcept Therapeutics Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CORT
# of Institutions
316Shares Held
88.2MCall Options Held
1.07MPut Options Held
973K-
Black Rock Inc. New York, NY16.5MShares$828 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$478 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$412 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$346 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$191 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.36B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...